2019 nCoV/COVID19 RBD protein (Recombinant) {Biotin} (STJP000261) STJP000261|產品目錄|代理商|上海91麻豆福利视频网生物科技有限公司

所在位置: 首頁> 產品目錄> S類> ST john's laboratory>

查看大圖

產品名稱：2019 nCoV/COVID19 RBD protein (Recombinant) {Biotin} (STJP000261)
產品型號：STJP000261
產品廠商：ST john's laboratory
產品文檔：

你添加了1件商品查看購物車

簡單介紹：

2019 nCoV/COVID19 RBD protein (Recombinant) {Biotin} (STJP000261)

詳情介紹：

Host:	CHO cells
Note:	STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description:	Recombinant-2019 nCoV/COVID19 RBD-protein was developed from cho cells. For use in research applications.

Conjugation:	Biotin
Formulation:	Lyophilised from 0.2 µm filtered PBS pH 7.4.
Dilution Range:	Spin the vial and reconstite in distilled water to a concentration not less than 0.1 mg/mL. This can then be diluted into other buffers.
Storage Instruction:	The lyophilized protein is stable for at least 1 year from date of receipt at-20°C. NA
Endotoxin:	Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg). NA
Immunoreactivity:	The activity was determined by immobilized human ACE2 Protein binding with biotinylated RBD in a functional ELISA assay, the linear was determined to be 10-100 ng/ml NA

Immunogen Region:	319-514 aa
Immunogen:	DNA sequence encoding the COVID-19 spike RBD protein domain [319-541] accession #6VSB_A including a C-terminal His AVI tag was expressed in CHO Cells. NA

Background

Recombinant 2019-nCoV RBD protein is a protein consisting of 250 amino acid residues, due to glycosylation migrates as an approximately 35kDa protein on SDS-PAGE.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance

姓名：

電話：

您的需求：

產品名稱：2019 nCoV/COVID19 RBD protein (Recombinant) {Biotin} (STJP000261)